Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Douglas S. Levine"'
Autor:
Douglas S. Levine, Douglas A. Drossman
Publikováno v:
Discover Health Systems. 1
Background The ills of the United States health care system have been debated for decades. Imbalance in the system’s strengths and performance shortfalls stem from misalignments among system participants. Methods We examine the conflicts that healt
Autor:
Douglas S Levine
Publikováno v:
Canadian Journal of Gastroenterology, Vol 7, Iss 2, Pp 187-195 (1993)
Externí odkaz:
https://doaj.org/article/bfb1c254bf954fb0833d809e3e7a5de1
Publikováno v:
The American Journal of Gastroenterology. 99:1437-1441
The aim of this article is to determine the severity of esophagitis and the response to treatment with proton-pump inhibitors in patients with and without evidence of Helicobacter pylori infection.This retrospective analysis evaluated data collected
Autor:
Thomas L. Vaughan, Peter S. Rabinovitch, Brian J. Reid, Patricia C. Galipeau, Patricia L. Blount, Alan R. Kristal, Douglas S. Levine, Carissa A. Sanchez, Laura J. Prevo, Rebecca E. Rudolph
Publikováno v:
JNCI Journal of the National Cancer Institute. 95:750-757
The incidence of esophageal adenocarcinoma has risen dramatically over the past three decades in the United States and in many other Western countries for reasons that are not well understood (1,2). Most esophageal adenocarcinomas arise in a metaplas
Autor:
Ronald Pruitt, David Sales, George Koval, John K Bell, Dennis Riff, Lawrence Wruble, Lorin K Johnson, Douglas S. Levine
Publikováno v:
The American Journal of Gastroenterology. 97:1398-1407
A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis
Publikováno v:
The American Journal of Gastroenterology. 96:3071-3083
OBJECTIVES: Barrett’s esophagus develops in 5–10% of patients with gastroesophageal reflux disease and predisposes to esophageal adenocarcinoma. We have previously shown that a systematic baseline endoscopic biopsy protocol using flow cytometry w
Autor:
Peter S. Rabinovitch, Patricia L. Blount, Brian J. Reid, Carissa A. Sanchez, Gary Longton, Patricia C. Galipeau, Douglas S. Levine, Laura J. Prevo
Publikováno v:
The American Journal of Gastroenterology. 96:2839-2848
Most patients with Barrett's esophagus do not progress to cancer, but those who do seem to have markedly increased survival when cancers are detected at an early stage. Most surveillance programs are based on histological assessment of dysplasia, but
Publikováno v:
The American Journal of Gastroenterology. 95:3089-3096
OBJECTIVE: The management of high-grade dysplasia (HGD) in Barrett’s esophagus remains controversial, in part, because of uncertainty about the ability of endoscopic biopsies to consistently detect early, curable cancers. METHODS: Here we report ca
Publikováno v:
American Journal of Gastroenterology. 94:80-85
The best treatment approach for patients with documented Barrett's esophagus remains controversial. There is currently no well designed prospective study examining the effect of successful antireflux surgery on Barrett's esophagus.Fourteen patients w
Autor:
Allen Farrand, David M. Hockenbery, Michelle E. Bouvier, Douglas S. Levine, Carol S. Murakami, Ted Gooley, George B. McDonald, Jean M. Stern
Publikováno v:
Gastroenterology. 115:28-35
Background & Aims: Beclomethasone dipropionate (BDP), a topically active steroid, seemed to be an effective treatment for intestinal graft-versus-host disease (GVHD) in a phase I study. The aim of this study was to compare the effectiveness of oral B